Prevention of Recurrence of Suicide Attempt by Adolescent by Sending SMS (MEDIACONNEX)
NCT02762734 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225
Last updated 2019-08-28
Summary
MEDIACONNEX study propose a new way of connectedness for adolescents after a suicide attempt: it is based on the sending of SMS (or mail or other new media), over a period of 6 months after their suicide attempt (SA), in order to allow them to recourse to the care more easily and so to limit the risk of suicidal recurrence. The MEDIACONNEX study will be a multicenter controlled randomized trial (East of France) and there is a funding from the Hospital. The proposal trial will test the hypothesis that adolescent suicide attempters who are receiving SMS (or mail or other new media) from the unit of care in addition to the usual care will do less SA recurrence, than those who are receiving the usual care.
The primary objective is to determine whether the use of SMS (or mail or other new media) to keep in touch with adolescent suicide attempters in addition to the usual care, compare to usual care, will reduce the delay of recurrence of suicide attempt during 6 months after the SA.
Conditions
- Suicide
Interventions
- OTHER
-
MEDIA
The intervention for the group MEDIA is a "keeping in touch" intervention through sending of SMS (or mail or other new media). The patient will receive 6 SMS (or mail or other new media) during 6 months after the suicide attempt. The first one 7 days after the suicide attempt and the last one after 6 months. The first SMS (or mail or other new media) is sent soon after the suicide attempt because studies on adult suicide attempters underline the importance of an early start for the connectedness measures. The text message are evolving in time, and are adapted to the genre of the adolescent.
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Principal Investigators
-
Fabienne LIGIER, Dr · Service de Psychiatrie de l'enfant et de l'adolescent, CHRU de Nancy
-
Catherine PICHENÉ, Dr · CPN, Unité d'Accueil des Urgences Psychiatriques
-
Philippe CHABERT, Dr · Unité de psychopathologie de l'adolescent Service Psychothérapique pour enfants et adolescents Pôle de Psychiatrie et Santé Mentale Hôpitaux Universitaires de Strasbourg
-
Sylvie NEZELOF, Dr · Service de Pédopsychiatrie Hôpital Jean Minjoz. CHRU de Besançon
-
Pascal PANNETIER, Dr · Service de Psychiatrie d'Urgence et de Liaison, dans les locaux du CHR Metz-Thionville Hôpital Mercy. CHR Metz-Thionville
-
Jean-Michel PINOIT, Dr · Service de Psychiatrie de l'enfant et de l'adolescent Hôpital d'enfants. CHU de Dijon
-
Anne-Catherine ROLLAND, Dr · Service de Psychothérapie de l'enfant et de l'adolescent Hôpital Robert Debré. CHU de Reims
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 13 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-13
- Primary Completion
- 2020-02-29
- Completion
- 2021-02-28
Countries
- France
Study Locations
More Related Trials
-
The Surrogate Project (Surrogate Storytelling)
NCT01902784 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of Closely Grouped, Iterative Exposures to Suxamethonium During ECT on the Sensitization to NMBA and the Development of Protective Antibodies
NCT05210062 ·Status: UNKNOWN
-
Sugammadex Dose Finding Under Two Years Old
NCT06575036 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome
NCT03419156 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Tolerance and Safety of Early Enteral Nutrition in Children After Percutaneous Endoscopic Gastrostomy Placement
NCT02777541 ·Status: UNKNOWN ·Phase: NA
-
Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
NCT03923556 ·Status: COMPLETED ·Phase: PHASE4
-
Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence
NCT02292628 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the ED
NCT06980727 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Burosumab in Children and Adolescents With X-linked Hypophosphatemia
NCT04419363 ·Status: UNKNOWN ·Phase: PHASE4
-
Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children
NCT02455921 ·Status: COMPLETED ·Phase: PHASE4
-
TubeClear® Evaluation in Pediatric Patients (Phase I)
NCT02724631 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence
NCT01380132 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Succinylcholine vs Rocuronium for Prehospital Emergency Intubation
NCT02000674 ·Status: COMPLETED ·Phase: PHASE3
-
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
NCT06035757 ·Status: RECRUITING ·Phase: PHASE4
-
A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
NCT05561647 ·Status: RECRUITING
-
"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"
NCT02375217 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
NCT00605826 ·Status: COMPLETED ·Phase: NA
-
Benefits of Amantadine in Patients With Coma State
NCT03443037 ·Status: UNKNOWN
-
Evaluation of Medical Care and Patient's Knowledge About the Behavior to Take on Secondary Prevention of Anaphylaxis
NCT03953482 ·Status: UNKNOWN
-
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
NCT01571297 ·Status: COMPLETED ·Phase: PHASE2
-
1-hour Premedication for Allergy Goal in Emergency: PAGE-1 Study
NCT07268248 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans
NCT02789241 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Dexamethasone on Sugammadex Reversal
NCT02137395 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)
NCT02813655 ·Status: TERMINATED ·Phase: PHASE2
-
Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants
NCT02708056 ·Status: COMPLETED ·Phase: PHASE4